eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0020538|hypertension |
| Sentences | 9 |
| PubMedID- 22610002 | Background & aims: little is known about the prevalence and severity of portal hypertension in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 24424317 | Investigated the prevalence and noninvasive predictors of portal hypertension in patients with nafld [21]. |
| PubMedID- 20644649 | Recent studies showed that nafld is closely associated with obesity, hypertension, dyslipidemia, and glucose intolerance, a cluster of metabolic disorders that is now recognized as metabolic syndrome [11], [12]. |
| PubMedID- 21561285 | Objective: hyperlipidemia, overweight, insulin resistance and hypertension are associated with non-alcoholic fatty liver disease. |
| PubMedID- 25680670 | Background & aims: risk factors for cardiovascular disease, such as obesity and hypertension, have been associated with nonalcoholic fatty liver disease. |
| PubMedID- 21915061 | nafld was independently associated with prevalent hypertension with an adjusted odds ratio of 1.71 (95% ci, 1.10-2.65, p=0.017). |
| PubMedID- 23341703 | We compared the relationships of alcoholic fatty liver and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia. |
| PubMedID- 22488593 | Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. |
| PubMedID- 26528424 | A large body of studies reveals that several metabolic conditions, such as obesity, insulin resistance, diabetes mellitus, dyslipidemia, and hypertension are strongly associated with nafld [4,16,21]. |
Page: 1